United States · FDA National Drug Code directory
Beleodaq
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72893-002_0af69daf-c3eb-436a-b8d9-8ae89c5f0c85
- Product NDC
- 72893-002
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Belinostat
- Labeler
- Acrotech Biopharma Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20140721
- Source listing expiry
- 20261231
Source-listed ingredients
- BELINOSTAT — 500 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (72893-002-01) / 10 mL in 1 VIAL · 72893-002-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →